• Home
  • About BIOI
    • Background
    • Aims and Scope
    • Editorial Board
    • Founding Editor
    • Peer Review
    • Abstracting and Indexing
    • Advertising
    • FAQs
    • Privacy Policy
    • Initiative for Open Citations
    • Use of Artificial Intelligence (AI) and Automated Tools Policy
  • For Authors
    • Author Guidelines
    • Peer Review
    • Article Types
    • Archiving
    • Copyright and Permissions
    • Repository Policy
    • Article Retraction
    • Publication Ethics & Malpractice Statement
    • Research Integrity Statement
  • For Reviewers
    • Editorial Workflow
    • Reviewer Guidelines
  • All Issues
  • News
    • Announcement
    • Press Releases
  • Submit
  • Contact Us
  • Home
  • About BIOI
    • Background
    • Aims and Scope
    • Editorial Board
    • Founding Editor
    • Peer Review
    • Abstracting and Indexing
    • Advertising
    • FAQs
    • Privacy Policy
    • Initiative for Open Citations
    • Use of Artificial Intelligence (AI) and Automated Tools Policy
  • For Authors
    • Author Guidelines
    • Peer Review
    • Article Types
    • Archiving
    • Copyright and Permissions
    • Repository Policy
    • Article Retraction
    • Publication Ethics & Malpractice Statement
    • Research Integrity Statement
  • For Reviewers
    • Editorial Workflow
    • Reviewer Guidelines
  • All Issues
  • News
    • Announcement
    • Press Releases
  • Submit
  • Contact Us
Bio Integration

  • Albinism-Associated Genes and Non-Skin Cancer: Bioinformatics Analysis of Relevant miRNAs

    Announcing a new article publication for BIO Integration journal that reports potential molecular links between albinism-associated genes and several non-skin cancers. While albinism is primarily connected to pigmentation changes and…

  • Anticancer Efficacy of 5-Fluorouracil-Loaded Chitin Nanohydrogel in Enhanced Skin Cancer Therapy

    Announcing a new article publication for BIO Integration journal. The pyrimidine analog 5-flurouracil (5-FU) is effective against solid tumors. However, the half-life of intravenously administered 5-FU is less than 20…

3.3
2024CiteScore
 
74th percentile
Powered by  Scopus

About the Journal

BIOI Volume 6

Published by Compuscript Publishing

Compuscript logo

© 2026 Bio Integration
  • About Us
  • For Advertisers
  • Help
We’ve updated our Privacy Policy and Cookies Policy . These updates address new privacy regulations in Europe and apply to everyone who uses the BIO Integration Journal website including authors, partners and members. Please click on “Accept” to continue to use this website under the new privacy policy and cookies policy.ACCEPT Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT